ANNA Satellite Symposium
( not part of the official ANNA Annual Meeting)

Welcome, Introduction and Program Overview
Andrea Easom, MA, MNSC, APRN, BC, CNN

Managing Patients With IV Iron and EPO: Practical Techniques (Part I)
Andrea Easom, MA, MNSC, APRN, BC, CNN
Managing Patients With IV Iron and EPO: Practical Techniques (Part II)
Andrea Easom, MA, MNSC, APRN, BC, CNN
Adjustable Dosing to Optimize Anemia Management: A Case Study Analysis
Deborah Bowe, RN, CNN
Panel Discussion
Andrea Easom, Deborah Bowe

  
At the conclusion of the certified activity, participants should be able to do the following:
Understand the importance of both EPO and IV iron in effective erythropoiesis
Review key K/DOQI recommendations for practical management of iron-deficiency anemia
Identify appropriate dosing practices to optimize patient outcomes

Andrea Easom, MA, MNSC, APRN, BC, CNN
Instructor, College of Medicine University of Arkansas for Medical Sciences Little Rock, Arkansas

Deborah Bowe, RN, CNN
Clinical Administrator Kidney Institute of Wisconsin, LLC Glendale, Wisconsin
This satellite symposium is sponsored by an unrestricted educational grant from Watson Pharma, Inc. This activity has been planned and produced in accordance with CE guidelines and policies. From a CE symposium held on April 5, 2005 at the American Nephrology Nurses' Association (ANNA) Annual Meeting in Nashville, TN. This symposium was approved by ANNA. It was not part of the official ANNA Annual Meeting.
This activity provides 1.8 contact hours. The American Nephrology Nurses’ Association (ANNA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. ANNA is a Provider approved by the California Board of Registered Nursing, provider number CEP 00910 for 1.8 contact hours.
Posting Date: September 15, 2006
CE Credit Eligible Through: September 15, 2008
CE Credit Hours/Completion Time: 1.8
Target Audiences: Nurses, nurse practitioners, and other healthcare professionals who treat and manage patients with CKD.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the linked abstracts in the post-test answer feedback material.
 
SPEAKER DISCLOSURE STATEMENT:
See individual talks.

SPONSORSHIP / SUPPORT :
This ANNA Satellite symposium was developed in conjunction with Fallon Medica, and the ANNA, and sponsored by a restricted educational grant from Watson Pharma, Inc.

ANNA and HDCN CE POLICY STATEMENTS:
The CE policy and disclosure statements of the American Nephrology Nurses' Association are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.
BACK TO
TOPIC INDEX :